| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.438 | 7.914 | 10.163 | 13.373 | 16.264 | 10.473 | 11.839 | 17.331 | 17.909 | 14.641 |
| Total Income - EUR | 6.438 | 7.914 | 10.252 | 13.394 | 16.315 | 13.807 | 12.023 | 17.331 | 31.172 | 14.641 |
| Total Expenses - EUR | 9.291 | 9.306 | 9.719 | 9.781 | 8.168 | 11.945 | 12.362 | 14.101 | 11.014 | 8.724 |
| Gross Profit/Loss - EUR | -2.853 | -1.392 | 533 | 3.613 | 8.148 | 1.863 | -339 | 3.229 | 20.158 | 5.917 |
| Net Profit/Loss - EUR | -3.046 | -1.630 | 227 | 3.222 | 7.658 | 1.470 | -671 | 2.719 | 16.805 | 4.992 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Smariderm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 6.219 | 3.420 | 672 | 0 | 16.488 | 12.131 | 7.908 | 3.966 | 0 | 0 |
| Current Assets | 999 | 2.156 | 5.026 | 11.955 | 12.149 | 5.389 | 9.061 | 1.896 | 20.468 | 21.103 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3 | 3 | 0 | 1 | 0 | 9 | 0 | 0 | 0 | 9 |
| Cash | 996 | 2.153 | 5.026 | 11.955 | 12.149 | 5.380 | 9.061 | 1.896 | 20.468 | 21.094 |
| Shareholders Funds | 7.099 | 5.397 | 5.532 | 8.653 | 16.143 | 17.308 | 16.253 | 4.081 | 16.918 | 19.631 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 119 | 178 | 165 | 3.302 | 12.493 | 212 | 717 | 1.781 | 3.550 | 1.472 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Smariderm S.r.l.